Pomanda estimates the enterprise value of SHAW HEALTHCARE (NAILSEA) LIMITED at £3.2m based on a Turnover of £4.5m and 0.72x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of SHAW HEALTHCARE (NAILSEA) LIMITED at £2.9m based on an EBITDA of £521.3k and a 5.5x industry multiple (adjusted for size and gross margin).
Pomanda estimates the enterprise value of SHAW HEALTHCARE (NAILSEA) LIMITED at £0 based on Net Assets of £-19m and 3.41x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Shaw Healthcare (nailsea) LimitedOverview
Shaw Healthcare (nailsea) Limited is a live company located in cardiff, CF3 0LT with a Companies House number of 06181148. It operates in the residential care activities for mental difficulties, mental health and substance abuse sector, SIC Code 87200. Founded in March 2007, it's largest shareholder is
shaw healthcare group ltd
with a 100% stake. Shaw Healthcare (nailsea) Limited is a established,
small sized company, Pomanda has estimated its turnover at
£4.5m with
healthy
growth in recent years.
Pomanda's financial health check has awarded Shaw Healthcare (Nailsea) Limited a 4.5 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 3 areas for improvement. Company Health Check FAQs
Health Rating4.5out of 5
4 Strong
4 Regular
3 Weak
Size
annual sales of £4.5m, make it in line with the average company (£3.8m)
£4.5m - Shaw Healthcare (nailsea) Limited
£3.8m - Industry AVG
Growth
3 year (CAGR) sales growth of 11%, show it is growing at a faster rate (7%)
11% - Shaw Healthcare (nailsea) Limited
7% - Industry AVG
Production
with a gross margin of 32.1%, this company has a comparable cost of product (32.1%)
32.1% - Shaw Healthcare (nailsea) Limited
32.1% - Industry AVG
Profitability
an operating margin of 9.7% make it more profitable than the average company (6%)
9.7% - Shaw Healthcare (nailsea) Limited
6% - Industry AVG
Employees
with 87 employees, this is similar to the industry average (92)
87 - Shaw Healthcare (nailsea) Limited
92 - Industry AVG
Pay Structure
on an average salary of £32.4k, the company has a higher pay structure (£25.5k)
£32.4k - Shaw Healthcare (nailsea) Limited
£25.5k - Industry AVG
Efficiency
resulting in sales per employee of £51.8k, this is more efficient (£39.9k)
£51.8k - Shaw Healthcare (nailsea) Limited
£39.9k - Industry AVG
Debtor Days
it gets paid by customers after 3 days, this is earlier than average (20 days)
3 days - Shaw Healthcare (nailsea) Limited
20 days - Industry AVG
Creditor Days
its suppliers are paid after 8 days, this is close to average (8 days)
8 days - Shaw Healthcare (nailsea) Limited
8 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- - Shaw Healthcare (nailsea) Limited
- - Industry AVG
Cash Balance
has cash to cover current liabilities
for 31 weeks, this is less cash available to meet short term requirements (55 weeks)
31 weeks - Shaw Healthcare (nailsea) Limited
55 weeks - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 432.4%, this is a higher level of debt than the average (35.6%)
432.4% - Shaw Healthcare (nailsea) Limited
35.6% - Industry AVG
SHAW HEALTHCARE (NAILSEA) LIMITED financials
EXPORT
Shaw Healthcare (Nailsea) Limited's latest turnover from March 2024 is £4.5 million and the company has net assets of -£19 million. According to their latest financial statements, Shaw Healthcare (Nailsea) Limited has 87 employees and maintains cash reserves of £2 million as reported in the balance sheet.
Data source:Companies House, Pomanda Estimates
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Mar 2012
Mar 2011
Mar 2010
Turnover
4,502,568
3,892,524
3,578,375
3,334,788
2,966,716
2,597,535
2,411,262
2,420,762
2,982,279
2,681,918
2,411,388
3,478,741
3,577,297
3,356,228
2,275,963
Other Income Or Grants
Cost Of Sales
3,058,896
2,587,770
2,362,652
2,158,640
1,988,122
1,711,682
1,524,202
1,476,904
1,727,082
1,564,630
1,421,600
2,046,781
2,055,334
1,900,616
1,282,172
Gross Profit
1,443,672
1,304,754
1,215,723
1,176,148
978,594
885,853
887,060
943,858
1,255,197
1,117,288
989,788
1,431,960
1,521,963
1,455,612
993,791
Admin Expenses
1,009,051
1,254,172
792,062
1,141,833
1,512,480
1,651,198
1,822,050
2,537,231
2,146,145
1,800,442
4,091,099
3,935,670
1,460,983
1,794,712
1,951,035
Operating Profit
434,621
50,582
423,661
34,315
-533,886
-765,345
-934,990
-1,593,373
-890,948
-683,154
-3,101,311
-2,503,710
60,980
-339,100
-957,244
Interest Payable
1,044,935
801,787
721,010
727,713
855,277
731,756
242,447
689,101
696,099
669,951
637,103
628,197
626,114
614,295
618,981
Interest Receivable
122,281
839,246
748,948
516,660
1,205
1,003
1,133
44,462
1,799
3,136
2,241
2,955
1,354
1,311
1,536
Pre-Tax Profit
-488,033
88,041
451,599
-176,738
-1,387,958
-1,496,098
-1,176,304
-2,238,012
-1,585,248
-1,349,969
-3,736,173
-3,128,952
-563,780
-952,084
-1,574,689
Tax
121,939
-44,440
-135,307
33,526
278,676
289,929
229,576
431,124
292,493
283,989
414,914
106,763
145,182
257,574
414,874
Profit After Tax
-366,094
43,601
316,292
-143,212
-1,109,282
-1,206,169
-946,728
-1,806,888
-1,292,755
-1,065,980
-3,321,259
-3,022,189
-418,598
-694,510
-1,159,815
Dividends Paid
Retained Profit
-366,094
43,601
316,292
-143,212
-1,109,282
-1,206,169
-946,728
-1,806,888
-1,292,755
-1,065,980
-3,321,259
-3,022,189
-418,598
-694,510
-1,159,815
Employee Costs
2,815,853
2,143,523
1,995,418
2,004,736
1,286,525
1,294,238
1,359,454
1,421,324
1,568,185
1,863,201
1,902,763
2,158,930
2,292,807
1,833,652
1,722,588
Number Of Employees
87
72
77
84
63
66
76
86
88
103
109
119
126
115
112
EBITDA*
521,291
144,900
511,979
109,064
-467,769
-673,998
-833,696
-1,492,974
-790,550
-582,531
-2,966,240
-2,331,665
238,347
-160,948
-789,297
* Earnings Before Interest, Tax, Depreciation and Amortisation
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Mar 2012
Mar 2011
Mar 2010
Tangible Assets
3,430,223
3,310,866
3,405,184
3,434,903
3,377,784
3,377,227
3,453,713
3,397,227
3,492,180
3,592,578
3,691,947
5,845,213
8,606,495
8,752,950
8,818,782
Intangible Assets
Investments & Other
Debtors (Due After 1 year)
51,757
107,734
195,195
286,219
Total Fixed Assets
3,430,223
3,310,866
3,405,184
3,434,903
3,377,784
3,377,227
3,505,470
3,504,961
3,687,375
3,878,797
3,691,947
5,845,213
8,606,495
8,752,950
8,818,782
Stock & work in progress
Trade Debtors
46,078
272,469
28,365
229,486
166,787
10,662
202,390
86,878
190,760
203,861
141,833
167,991
150,810
147,717
165,071
Group Debtors
199,019
36,693
83,541
330,548
343,610
285,553
518,531
391,606
302,229
408,095
124,144
185,813
308,515
447,474
Misc Debtors
34,658
14,715
54,605
13,340
20,349
14,117
19,854
16,861
15,986
13,643
12,851
13,444
3,513
6,145
9,620
Cash
2,019,614
1,738,427
1,619,012
1,529,523
1,340,394
1,448,523
1,182,951
1,188,285
1,001,650
882,957
763,088
823,662
505,487
418,863
308,577
misc current assets
total current assets
2,299,369
2,062,304
1,701,982
1,855,890
1,858,078
1,816,912
1,690,748
1,810,555
1,600,002
1,402,690
1,325,867
1,129,241
845,623
881,240
930,742
total assets
5,729,592
5,373,170
5,107,166
5,290,793
5,235,862
5,194,139
5,196,218
5,315,516
5,287,377
5,281,487
5,017,814
6,974,454
9,452,118
9,634,190
9,749,524
Bank overdraft
Bank loan
359,699
324,828
269,091
230,632
224,655
253,608
228,122
192,884
160,421
129,338
120,800
26,772
1,826
1,826
1,824
Trade Creditors
67,148
89,432
128,309
69,205
118,397
118,868
100,214
166,516
156,727
80,768
60,841
140,614
50,449
125,384
131,656
Group/Directors Accounts
2,453,569
1,881,156
1,549,868
1,281,806
1,022,671
786,484
587,440
389,645
243,757
115,340
604
138,289
74,252
82,555
122,235
other short term finances
27,907
25,782
23,851
22,016
20,471
18,926
17,478
16,126
14,967
13,808
12,746
67,011
hp & lease commitments
other current liabilities
460,746
421,014
217,498
460,726
388,273
268,259
328,077
505,641
403,535
303,410
245,256
492,697
307,265
260,123
226,251
total current liabilities
3,369,069
2,742,212
2,188,617
2,064,385
1,774,467
1,446,145
1,261,331
1,270,812
979,407
642,664
440,247
865,383
433,792
469,888
481,966
loans
20,995,056
20,976,477
21,389,963
22,131,713
22,300,164
21,530,593
20,513,127
19,676,216
18,132,594
17,170,692
13,318,434
11,520,470
11,428,701
11,202,599
10,649,731
hp & lease commitments
Accruals and Deferred Income
other liabilities
provisions
408,571
331,491
249,197
131,598
54,922
1,810
304,700
312,909
291,744
245,224
206,838
total long term liabilities
21,403,627
21,307,968
21,639,160
22,263,311
22,355,086
21,532,403
20,513,127
19,676,216
18,132,594
17,170,692
13,623,134
11,833,379
11,720,445
11,447,823
10,856,569
total liabilities
24,772,696
24,050,180
23,827,777
24,327,696
24,129,553
22,978,548
21,774,458
20,947,028
19,112,001
17,813,356
14,063,381
12,698,762
12,154,237
11,917,711
11,338,535
net assets
-19,043,104
-18,677,010
-18,720,611
-19,036,903
-18,893,691
-17,784,409
-16,578,240
-15,631,512
-13,824,624
-12,531,869
-9,045,567
-5,724,308
-2,702,119
-2,283,521
-1,589,011
total shareholders funds
-19,043,104
-18,677,010
-18,720,611
-19,036,903
-18,893,691
-17,784,409
-16,578,240
-15,631,512
-13,824,624
-12,531,869
-9,045,567
-5,724,308
-2,702,119
-2,283,521
-1,589,011
Mar 2024
Mar 2023
Mar 2022
Mar 2021
Mar 2020
Mar 2019
Mar 2018
Mar 2017
Mar 2016
Mar 2015
Mar 2014
Mar 2013
Mar 2012
Mar 2011
Mar 2010
Operating Activities
Operating Profit
434,621
50,582
423,661
34,315
-533,886
-765,345
-934,990
-1,593,373
-890,948
-683,154
-3,101,311
-2,503,710
60,980
-339,100
-957,244
Depreciation
86,670
94,318
88,318
74,749
66,117
91,347
101,294
100,399
100,398
100,623
135,071
172,045
177,367
178,152
167,947
Amortisation
Tax
121,939
-44,440
-135,307
33,526
278,676
289,929
229,576
431,124
292,493
283,989
414,914
106,763
145,182
257,574
414,874
Stock
Debtors
-44,122
240,907
-243,397
-191,317
149,295
-191,165
-170,450
-63,543
-12,405
243,173
257,200
-34,557
-122,241
-159,788
622,165
Creditors
-22,284
-38,877
59,104
-49,192
-471
18,654
-66,302
9,789
75,959
19,927
-79,773
90,165
-74,935
-6,272
131,656
Accruals and Deferred Income
39,732
203,516
-243,228
72,453
120,014
-59,818
-177,564
102,106
100,125
58,154
-247,441
185,432
47,142
33,872
226,251
Deferred Taxes & Provisions
77,080
82,294
117,599
76,676
53,112
1,810
-304,700
-8,209
21,165
46,520
38,386
206,838
Cash flow from operations
781,880
106,486
553,544
433,844
-165,733
-232,258
-677,536
-886,412
-309,568
-768,334
-3,143,949
-1,893,583
524,497
322,400
-431,843
Investing Activities
capital expenditure
-206,027
-58,599
-131,868
-66,674
-14,861
-157,780
-5,446
-1,254
2,018,195
2,589,237
-30,912
-112,320
-8,986,729
Change in Investments
cash flow from investments
-206,027
-58,599
-131,868
-66,674
-14,861
-157,780
-5,446
-1,254
2,018,195
2,589,237
-30,912
-112,320
-8,986,729
Financing Activities
Bank loans
34,871
55,737
38,459
5,977
-28,953
25,486
35,238
32,463
31,083
8,538
94,028
24,946
2
1,824
Group/Directors Accounts
572,413
331,288
268,062
259,135
236,187
199,044
197,795
145,888
128,417
114,736
-137,685
64,037
-8,303
-39,680
122,235
Other Short Term Loans
2,125
1,931
1,835
1,545
1,545
1,448
1,352
1,159
1,159
1,062
-54,265
67,011
Long term loans
18,579
-413,486
-741,750
-168,451
769,571
1,017,466
836,911
1,543,622
961,902
3,852,258
1,797,964
91,769
226,102
552,868
10,649,731
Hire Purchase and Lease Commitments
other long term liabilities
share issue
-2,420,322
-429,196
interest
-922,654
37,459
27,938
-211,053
-854,072
-730,753
-241,314
-644,639
-694,300
-666,815
-634,862
-625,242
-624,760
-612,984
-617,445
cash flow from financing
-294,666
12,929
-405,456
-112,847
124,278
512,691
829,982
1,078,493
428,261
889,457
1,065,180
-377,479
-406,961
-99,794
9,727,149
cash and cash equivalents
cash
281,187
119,415
89,489
189,129
-108,129
265,572
-5,334
186,635
118,693
119,869
-60,574
318,175
86,624
110,286
308,577
overdraft
change in cash
281,187
119,415
89,489
189,129
-108,129
265,572
-5,334
186,635
118,693
119,869
-60,574
318,175
86,624
110,286
308,577
shaw healthcare (nailsea) limited Credit Report and Business Information
Very Low Risk70 - 100
Low Risk50 - 70
Moderate Risk30 - 50
High Risk20 - 30
Very High Risk0 - 20
Get a comprehensive credit check for shaw healthcare (nailsea) limited. Get real-time insights into shaw healthcare (nailsea) limited's credit score, group structure and payment trends.
Perform a competitor analysis for shaw healthcare (nailsea) limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in CF3 area or any other competitors across 12 key performance metrics.
shaw healthcare (nailsea) limited Ownership
SHAW HEALTHCARE (NAILSEA) LIMITED group structure
Shaw Healthcare (Nailsea) Limited has no subsidiary companies.
The sole shareholder of Shaw Healthcare (Nailsea) Limited is Shaw Healthcare Group Ltd.
shaw healthcare group ltd
100%
shaw healthcare (nailsea) limited directors
Shaw Healthcare (Nailsea) Limited currently has 2 directors.
The longest serving directors include
Mr Russell Brown (May 2009) and
Mr Gareth Morgan (Nov 2021).
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 2 charges/mortgages relating to shaw healthcare (nailsea) limited. Currently there are 2 open charges and 0 have been satisfied in the past.
shaw healthcare (nailsea) limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for SHAW HEALTHCARE (NAILSEA) LIMITED. This can take several minutes, an email will notify you when this has completed.
shaw healthcare (nailsea) limitedCompanies House Filings - See Documents
